Instil Bio Inc TIL

Healthcare Biotechnology

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR), platform. The Company's lead CoStAR-TIL product candidate, ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (Fra), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer. CAR-T and TCR-T therapies are cell products composed of T cells that have been genetically engineered to recognize a specific cancer-related antigen on the surface of tumor cells.

NDAQ:TIL - Post by User

Instil Bio Inc

Bullboard Posts

Post by brahmabullzon Aug 25, 2011 5:25pm

332 Views

Post# 18980166

Nice paint at the close..

I've flipped GPD at higher prices in the past ... but loaded the boat huge at the bell today.
GPD hit 1.48 just a couple weeks back. Can it really get much lower from these levels .. I bet not -- definitely not past .90 in the worst case scenario.
Consider all the bids that have been filled on this latest slide down from 1.16-1.17. Its plain obvious that investors see value at these levels and are willing to step up.
Buy low, sell high .. easy money
GLTA!
BB

Bullboard Posts

98% energy efficiency: How Acceleware's EM Technology is transforming heat solutions